Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
暂无分享，去创建一个
A. Grothey | M. Fakih | F. Ciardiello | Z. Wainberg | G. Meinhardt | K. Raghav | S. Siena | F. Loupakis | K. Saxena | T. Yoshino | T. Nishina | Javier Rodríguez | Y. Okuda | K. Yamaguchi | H. Kawakami | M. Di Bartolomeo | T. Masuishi | E. Bako | E. Élez | Kojiro Kobayashi